DRRX

DRRX

USD

DURECT Corporation Common Stock

$1.910-0.020 (-1.036%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Ameerika Ühendriigid

Hinnagraafik

Graafiku andmed pole saadaval

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.930

Kõrge

$1.910

Madal

$1.910

Maht

N/A

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

59.3M

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

United States

Kauplemisstatistika

Keskmine maht

1.36M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $0.4801Praegune $1.910Kõrge $2.64

Seotud uudised

AccessWire

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. , a global, diversified pharmaceutical company, and DURECT Corporation today announced that

Vaata rohkem
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Vaata rohkem
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders
PR Newswire

DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the second quarter ended June 30, 2025 and provided an update on the...

Vaata rohkem
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health